Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18027311 | NON-INVASIVE FUNCTIONAL COMPANION ASSAYS FOR ONCOGENE TARGETED THERAPY FOR BRAIN CANCER | Non-Final OA | The Regents of the University of California |
| 17997295 | METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITS | Non-Final OA | Novartis AG |
| 17997299 | METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITS | Non-Final OA | Novartis AG |
| 19266396 | ZWITTERIONIC METAL CHELATORS | Final Rejection | Curadel Surgical Innovations, Inc. |
| 17823707 | ERGOTHIONEINE PET COMPOUNDS AND METHODS OF USE THEREOF | Non-Final OA | VANDERBILT UNIVERSITY |
| 17550542 | BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY | Final Rejection | The Johns Hopkins University |
| 17264222 | COMPETITIVE PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) BINDING AGENTS FOR REDUCTION OF NON-TARGET ORGAN UPTAKE OF RADIOLABELED PSMA INHIBITORS FOR PSMA POSITIVE TUMOR IMAGING AND RADIOPHARMACEUTICAL THERAPY | Non-Final OA | The Johns Hopkins University |
| 17253336 | POSITRON EMISSION TOMOGRAPHY (PET) RADIOTRACERS FOR IMAGING MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R) IN NEUROINFLAMMATION | Non-Final OA | The Johns Hopkins University |
| 17919848 | Fluorinated Derivatives of Gabapentin and Methods of Use Thereof | Final Rejection | The General Hospital Corporation |
| 18542674 | HEAT RESISTANT GENERATOR COLUMNS FOR ELUTION SYSTEMS | Final Rejection | Jubilant Draximage Inc. |
| 17705781 | Multi-Enzyme Nanoparticle-Assisted Stable Isotope Incorporation Into Small Molecules by Channeling | Non-Final OA | The Government of the United States of America, as represented by the Secretary of the Navy |
| 18729913 | PEPTIDE UREA DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE UREA DERIVATIVE, AND APPLICATION OF PEPTIDE UREA DERIVATIVE | Final Rejection | BIVISION PHARMACEUTICALS, INC |
| 18029596 | METHODS AND COMPOSITIONS FOR INCREASING UPTAKE, INTERNALIZATION, AND/OR RETENTION OF SMALL MOLECULE LIGANDS | Non-Final OA | CORNELL UNIVERSITY |
| 18247427 | METHODS AND COMPOSITIONS FOR SYNERGISTIC UPTAKE AND RETENTION OF SMALL MOLECULE LIGANDS | Non-Final OA | CORNELL UNIVERSITY |
| 17725271 | BIOREDUCTIVELY-ACTIVATED COMPOUNDS, THEIR PRODRUGS, RADIOPHARMACEUTICALS, THE COMPOSITIONS, AND THEIR APPLICATIONS IN MULTIMODAL THERANOSTIC MANAGEMENT OF HYPOXIA DISEASES INCLUDING CANCER | Final Rejection | The Governors of the University of Alberta |
| 18666047 | SHELF-STABLE FORMULATIONS OF BENZOYL PEROXIDE AND METHODS OF PRODUCING SAME | Final Rejection | BLUE HILL TECHNOLOGIES LLC |
| 18632964 | Imaging Agents | Non-Final OA | UCB Biopharma SRL |
| 18628420 | COMPLEX COMPRISING A PSMA-TARGETING COMPOUND LINKED TO A LEAD OR THORIUM RADIONUCLIDE | Final Rejection | Sciencons AS |
| 18603721 | COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES | Non-Final OA | Wake Forest University Health Sciences |
| 17922583 | COPPER-CONTAINING THERAGNOSTIC COMPOSITIONS AND METHODS OF USE | Final Rejection | The University of Melbourne |
| 18384509 | MOF FOR RADIOTHERAPY | Final Rejection | Node Pharma AS |
| 17793089 | ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS AND THEIR USE IN HYPERPOLARIZED IMAGING | Non-Final OA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC |
| 17631600 | RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS | Non-Final OA | THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Servic |
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | Final Rejection | Georgia State University Research Foundation, Inc. |
| 18246944 | MACROCYCLIC HOST MOLECULE-BASED CORE-SHELL NANOPARTICLES AND METHOD FOR SYNTHESIZING SAME | Non-Final OA | BIONANO HEALTH GUARD RESEARCH CENTER |
| 18260272 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | Non-Final OA | TECHNISCHE UNIVERSITÄT MÜNCHEN - KLINIKUM RECHTS DER ISAR |
| 18343960 | METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES | Non-Final OA | UNIVERSITY OF OTTAWA |
| 18301896 | METHOD OF SYNTHESIZING 18F RADIOLABELED BIOMOLECULAR AGENTS | Non-Final OA | Theracea Pharma, LC |
| 18044356 | METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJUNCTION WITH LINTUZUMAB-AC225 | Non-Final OA | ACTINIUM PHARMACEUTICALS, INC. |
| 17802190 | THIOPURINE-BASED COMPOUND, COMPOSITION, METHOD OF PREPARATION AND APPLICATIONS | Non-Final OA | SEECURE TAIWAN CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy